PollNowData
Back to companies

REGENXBIO Inc.

RGNXUSNASDAQPharmaceuticals & Healthcare

REGENXBIO Inc.

Revenue
$170.4mn
YoY +104.5%
Operating income
-$161.2mn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API